Open Access

5-year outcomes of target all comers randomised trial & prospects of target series clinical trials

Event: ESC Congress 2022
Topic: Interventional Cardiology
Session type: Satellite Symposium
sponsored by MicroPort Scientific Corporation
Date: 29 August 2022
Time: 12:45 - 13:45

Congress Session

This content is currently on OPEN ACCESS

Sign in to view the resources

8 presentations in this session

Opening & target AC project introduction.

Speaker: Professor A. Baumbach (London, GB)
Thumbnail

5-year outcomes of target all comers randomised trial.

Speaker: Doctor A. Lansky (New Haven, US)
Thumbnail

Group discussion.

Speaker: Professor B. Xu (Beijing, CN)
Speaker: Doctor L. Janssens (Bonheiden, BE)
Speaker: Doctor L. Holmvang (Copenhagen, DK)
Speaker: Doctor T. Johnson (Bristol, GB)
Thumbnail

TARGET AC sub-group analysis on diabetics and ACS patients.

Speaker: Professor N. van Royen (Nijmegen, NL)
Thumbnail

Group discussion.

Speaker: Professor B. Xu (Beijing, CN)
Speaker: Doctor L. Holmvang (Copenhagen, DK)
Speaker: Doctor L. Janssens (Bonheiden, BE)
Speaker: Doctor T. Johnson (Bristol, GB)
Thumbnail

Prospects of target series clinical trials.

Speaker: Associate Professor G. Tarantini (Padua, IT)
Thumbnail

Group discussion.

Speaker: Professor B. Xu (Beijing, CN)
Speaker: Doctor L. Holmvang (Copenhagen, DK)
Speaker: Doctor L. Janssens (Bonheiden, BE)
Speaker: Doctor T. Johnson (Bristol, GB)
Thumbnail

Closing.

Speaker: Professor A. Baumbach (London, GB)
Thumbnail

17 speakers from this session

Professor Andreas Baumbach

St Bartholomews and Queen Mary University, London (United Kingdom of Great Britain & Northern Ireland)
11 presentations
1 follower

Doctor Alexandra J Lansky

Yale School of Medicine, New Haven (United States of America)
7 presentations
1 follower

Professor Bo Xu

State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular D, Beijing (China)
4 presentations
0 follower

Doctor Luc Janssens

Imelda Hospital, Bonheiden (Belgium)
3 presentations
0 follower

Doctor Lene Holmvang

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)
9 presentations
0 follower

Doctor Thomas Johnson

Bristol Heart Institute, Bristol (United Kingdom of Great Britain & Northern Ireland)
3 presentations
0 follower

Professor Niels van Royen

Radboud University Nijmegen, Nijmegen (Netherlands (The))
3 presentations
0 follower

Professor Bo Xu

State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular D, Beijing (China)
4 presentations
0 follower

Doctor Lene Holmvang

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)
9 presentations
0 follower

Doctor Luc Janssens

Imelda Hospital, Bonheiden (Belgium)
3 presentations
0 follower

Doctor Thomas Johnson

Bristol Heart Institute, Bristol (United Kingdom of Great Britain & Northern Ireland)
3 presentations
0 follower

Associate Professor Giuseppe Tarantini

University Hospital of Padova, Padua (Italy)
9 presentations
1 follower

Professor Bo Xu

State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular D, Beijing (China)
4 presentations
0 follower

Doctor Lene Holmvang

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)
9 presentations
0 follower

Doctor Luc Janssens

Imelda Hospital, Bonheiden (Belgium)
3 presentations
0 follower

Doctor Thomas Johnson

Bristol Heart Institute, Bristol (United Kingdom of Great Britain & Northern Ireland)
3 presentations
0 follower

Professor Andreas Baumbach

St Bartholomews and Queen Mary University, London (United Kingdom of Great Britain & Northern Ireland)
11 presentations
1 follower

This platform is supported by

logo Novo Nordisk